|
| [February 27, 2013] |
 |
St. Jude Medical to Present at the Barclays Global Healthcare Conference
ST. PAUL, Minn. --(Business Wire)--
St. Jude Medical, Inc. (NYSE:STJ) will present at the Barclays Global
Healthcare Conference on Tuesday, March 12, in Miami. John Heinmiller,
executive vice president, will address the conference at 10:15 a.m. EDT.
The presentation will also be webcast live at www.sjm.com.
About St. Jude Medical
St. Jude Medical, Inc. develops medical technology and services that
focus on putting more control into the hands of those who treat cardiac,
neurological and chronic pain patients worldwide. The company is
dedicated to advancing the practice of medicine by reducing risk
wherever possible and contributing to successful outcomes for every
patent. St. Jude Medical is headquartered in St. Paul, Minn. and has
four major focus areas that include cardiac rhythm management, atrial
fibrillation, cardiovascular and neuromodulation. For more information,
please visit www.sjm.com.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve
risks and uncertainties. Such forward-looking statements include the
expectations, plans and prospects for the Company, including potential
clinical successes, anticipated regulatory approvals and future product
launches, and projected revenues, margins, earnings and market shares.
The statements made by the Company are based upon management's current
expectations and are subject to certain risks and uncertainties that
could cause actual results to differ materially from those described in
the forward-looking statements. These risks and uncertainties include
market conditions and other factors beyond the Company's control and the
risk factors and other cautionary statements described in the Company's
filings with the SEC (News - Alert), including those described in the Risk Factors and
Cautionary Statements sections of the Company's Annual Report on Form
10-K for the fiscal year ended December 29, 2012. The Company does not
intend to update these statements and undertakes no duty to any person
to provide any such update under any circumstance.

[ Back To Technology News's Homepage ]
|